Hormone therapy can sound like a very big decision before anyone has explained what the words mean. For menopause, it generally means using estrogen, sometimes with a progestogen, to treat particular symptoms. It is one option in a conversation about how you feel and what matters to you.
You do not have to arrive at an appointment already knowing which treatment you want. Start by describing the changes you have noticed, their effect on your day, and your health history. This guide can help you find the language for that conversation.
Begin with the symptom you want help with, then ask which options fit your medical history.
What would you like to feel easier?
Hot flashes, night sweats, and vaginal dryness can all enter the menopause conversation, but they do not always need the same treatment. Systemic hormone therapy circulates through the body; some low-dose vaginal treatments focus on local symptoms. A change in sleep or mood may also deserve assessment for other causes.
Write down what happens, how often, and how it affects ordinary activities. Our conversation starter offers prompts without asking you to share a medical history online.
Reading behind this section: ACOG: hormone therapy for menopause · ACOG: the menopause years
The treatment name is only the beginning
A patch, pill, gel, or vaginal product describes a route, not the whole prescription. Dose, formulation, and whether treatment is local or systemic matter. A person with a uterus who uses systemic estrogen generally also needs a progestogen to protect the uterine lining. A clinician should explain how that applies to the exact product.
The local and systemic comparison makes these distinctions easier to discuss. There is no single hormone plan that follows automatically from reaching a birthday.
Reading behind this section: ACOG: hormone therapy for menopause
Make room for the risk discussion
Your age, time since menopause, bleeding history, and conditions such as cancer, blood clots, cardiovascular disease, or liver disease can affect the recommendation. Treatment decisions should include both expected symptom benefit and potential harm, with follow-up to reconsider the balance.
Our benefits and risks guide explains why a changed warning label is not the same as a risk-free medicine. Hormone therapy is not a general promise to prevent aging or heart disease.
Reading behind this section: ACOG: hormone therapy for menopause · FDA: February 2026 hormone-therapy labeling update
Leave with a next step
Ask when to review symptoms, who to contact about problems, and what the next appointment will cost. If hormones are not suitable or not your preference, ask about alternatives for the symptom that brought you in. You can also ask for time to consider the choices.
Before choosing an online service, read the care comparisons and cost guide. A subscription and a prescription answer different questions, and neither replaces a clinical assessment.
Reading behind this section: ACOG: hormone therapy for menopause · Midi Health: pricing and insurance · Evernow: current FAQs
Our source notes
- ACOG: hormone therapy for menopause
Clinical patient guidance; individual history and the actual product label still govern treatment decisions.
- ACOG: the menopause years
Patient education about the menopause transition and treatment options.
- FDA: February 2026 hormone-therapy labeling update
Announcement of approved changes to six products; not proof that every warning on every product has disappeared.
- Midi Health: pricing and insurance
Provider prices and coverage descriptions; not a verified claim for any individual insurance policy.
- Evernow: current FAQs
Public care models and prices checked September 23, 2026; medication and visit costs may be separate.
